Physician profile
Joshua Modlin
NPI 1912285479
$793.06
in general payments reported to CMS, 2019-2025
11 companies · $50.74 in 2025
The $50.74 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $365 · 2020: $44.69 · 2021: $173 · 2022: $110 · 2023: $50.68 · 2025: $50.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $101.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $161.33 | 2019-2022 | |
| Stryker Corporation | $124.02 | 2019-2021 | |
| Horizon Therapeutics Plc | $111.06 | 2021-2023 | Krystexxa |
| Musculoskeletal Transplant Foundation INC. | $94.51 | 2019 | |
| Acera Surgical, INC. | $92.05 | 2019 | |
| Smith+Nephew, INC. | $68.58 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $46.48 | 2019 | |
| Curonix LLC | $30.76 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Paratek Pharmaceuticals, INC. | $24.18 | 2023 | Nuzyra |
| Nabriva Therapeutics, Plc | $20.11 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.98 | 2025 | Jublia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Modlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.